Role of the NF-κB transcription factor c-Rel in the generation of CD8+T-cell responses to Toxoplasma gondii

International Immunology

Volumn 22, Issue 11, 2010, Pages 851-861

  Jordan, Kimberly A ^a   Dupont, Christopher D ^a   Tait, Elia D ^a   Liou, Hsiou Chi ^b   Hunter, Christopher A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Adaptive immune response; Cytokines; Immunization; Inflammation; Memory; Parasite infection

Indexed keywords

ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OVALBUMIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR REL;

ADAPTIVE IMMUNITY; ADOPTIVE TRANSFER; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; BACTERIAL STRAIN; CD8+ T LYMPHOCYTE; CELL COUNT; CELL FUNCTION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; ENVIRONMENTAL FACTOR; GENE; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOCOMPETENT CELL; INFECTION; INFLAMMATION; LYMPHOCYTE FUNCTION; MOUSE; MOUSE STRAIN; NONHUMAN; OOCYTE; ORGANISM; PARASITE; PRIORITY JOURNAL; PROTOZOON; RECIPIENT; REGULATORY MECHANISM; SURVIVAL; T LYMPHOCYTE; TOXOPLASMA GONDII; VIRULENCE; WILD TYPE; ANIMAL; C57BL MOUSE; IMMUNOLOGY; METABOLISM; TOXOPLASMA;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; MICE; MICE, INBRED C57BL; PROTO-ONCOGENE PROTEINS C-REL; TOXOPLASMA;

EID: 78649796996     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxq439     Document Type: Article

References (68)

1. Ghosh, S., May, M. J. and Kopp, E. B. 1998. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16:225.
2. Baeuerle, P. A. and Henkel, T. 1994. Function and activation of NFkappa B in the immune system. Annu. Rev. Immunol. 12:141.
3. Vallabhapurapu, S. and Karin, M. 2009. Regulation and function of NF-kappaB transcription factors in the immune system. Annu. Rev. Immunol. 27:693.
4. Moore, B. E. and Bose, H. R. Jr. 1989. Expression of the c-rel and c-myc proto-oncogenes in avian tissues. Oncogene 4:845.
5. Grumont, R. J. and Gerondakis, S. 1990. The murine c-rel protooncogene encodes two mRNAs the expression of which is modulated by lymphoid stimuli. Oncogene Res. 5:245.
6. Brownell, E., Mathieson, B., Young, H. A., Keller, J., Ihle, J. N. and Rice, N. R. 1987. Detection of c-rel-related transcripts in mouse hematopoietic tissues, fractionated lymphocyte populations, and cell lines. Mol. Cell. Biol. 7:1304.
7. Gilmore, T. D. 1992. Role of rel family genes in normal and malignant lymphoid cell growth. Cancer Surv. 15:69.
8. Davis, J. N., Bargmann, W. and Bose, H. R. Jr. 1990. Identification of protein complexes containing the c-rel proto-oncogene product in avian hematopoietic cells. Oncogene 5:1109.
9. Bunting, K., Rao, S., Hardy, K. et al. 2007. Genome-wide analysis of gene expression in T cells to identify targets of the NF-kappa B transcription factor c-Rel. J. Immunol. 178:7097.
10. Kontgen, F., Grumont, R. J., Strasser, A. et al. 1995. Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. Genes Dev. 9:1965.
11. Hilliard, B. A., Mason, N., Xu, L. et al. 2002. Critical roles of c-Rel in autoimmune inflammation and helper T cell differentiation. J. Clin. Invest. 110:843.
12. Lamhamedi-Cherradi, S. E., Zheng, S., Hilliard, B. A. et al. 2003. Transcriptional regulation of type I diabetes by NF-kappa B. J. Immunol. 171:4886.
13. Wang, Y., Rickman, B. H., Poutahidis, T. et al. 2008. c-Rel is essential for the development of innate and T cell-induced colitis. J. Immunol. 180:8118.
14. Harling-McNabb, L., Deliyannis, G., Jackson, D. C., Gerondakis, S., Grigoriadis, G. and Brown, L. E. 1999. Mice lacking the transcription factor subunit Rel can clear an influenza infection and have functional anti-viral cytotoxic T cells but do not develop an optimal antibody response. Int. Immunol. 11:1431.
15. Mintern, J. D., Belz, G., Gerondakis, S., Carbone, F. R. and Heath, W. R. 2002. The cross-priming APC requires a Rel-dependent signal to induce CTL. J. Immunol. 168:3283.
16. Artis, D., Shapira, S., Mason, N. et al. 2002. Differential requirement for NF-kappa B family members in control of helminth infection and intestinal inflammation. J. Immunol. 169:4481.
17. Mason, N., Aliberti, J., Caamano, J. C., Liou, H. C. and Hunter, C. A. 2002. Cutting edge: identification of c-Rel-dependent and-independent pathways of IL-12 production during infectious and inflammatory stimuli. J. Immunol. 168:2590.
18. Tato, C. M., Villarino, A., Caamano, J. H., Boothby, M. and Hunter, C. A. 2003. Inhibition of NF-kappa B activity in T and NK cells results in defective effector cell expansion and production of IFN-gamma required for resistance to Toxoplasma gondii. J. Immunol. 170:3139.
19. Mason, N. J., Liou, H. C. and Hunter, C. A. 2004. T cell-intrinsic expression of c-Rel regulates Th1 cell responses essential for resistance to Toxoplasma gondii. J. Immunol. 172:3704.
20. Caamano, J., Alexander, J., Craig, L., Bravo, R. and Hunter, C. A. 1999. The NF-kappa B family member RelB is required for innate and adaptive immunity to Toxoplasma gondii. J. Immunol. 163:4453.
21. Caamano, J., Tato, C., Cai, G. et al. 2000. Identification of a role for NF-kappa B2 in the regulation of apoptosis and in maintenance of T cell-mediated immunity to Toxoplasma gondii. J. Immunol. 165:5720.
22. Suzuki, Y., Orellana, M. A., Schreiber, R. D. and Remington, J. S. 1988. Interferon-gamma: the major mediator of resistance against Toxoplasma gondii. Science 240:516.
23. Gazzinelli, R. T., Hieny, S., Wynn, T. A., Wolf, S. and Sher, A. 1993. Interleukin 12 is required for the T-lymphocyte-independent induction of interferon gamma by an intracellular parasite and induces resistance in T-cell-deficient hosts. Proc. Natl Acad. Sci. USA 90:6115.
24. Gazzinelli, R. T., Hakim, F. T., Hieny, S., Shearer, G. M. and Sher, A. 1991. Synergistic role of CD4+ and CD8+ T lymphocytes in IFNgamma production and protective immunity induced by an attenuated Toxoplasma gondii vaccine. J. Immunol. 146:286.
25. Mason, N. J., Artis, D. and Hunter, C. A. 2004. New lessons from old pathogens: what parasitic infections have taught us about the role of nuclear factor-kappaB in the regulation of immunity. Immunol. Rev. 201:48.
26. Jordan, K. A., Wilson, E. H., Tait, E. D. et al. 2009. Kinetics and phenotype of vaccine-induced CD8+ T cell responses to Toxoplasma gondii. Infect. Immun. 77:3894.
27. Dzierszinski, F., Pepper, M., Stumhofer, J. S. et al. 2007. Presentation of Toxoplasma gondii antigens via the endogenous Mhc class I pathway in non-professional and professional antigen presenting cells. Infect Immun. 75:5200.
28. Tumang, J. R., Owyang, A., Andjelic, S. et al. 1998. c-Rel is essential for B lymphocyte survival and cell cycle progression. Eur. J. Immunol. 28:4299.
29. Mrass, P., Takano, H., Ng, L. G. et al. 2006. Random migration precedes stable target cell interactions of tumor-infiltrating T cells. J. Exp. Med. 203:2749.
30. Hogquist, K. A., Jameson, S. C., Heath, W. R., Howard, J. L., Bevan, M. J. and Carbone, F. R. 1994. T cell receptor antagonist peptides induce positive selection. Cell 76:17.
31. Mombaerts, P., Iacomini, J., Johnson, R. S., Herrup, K., Tonegawa, S. and Papaioannou, V. E. 1992. RAG-1-deficient mice have no mature B and T lymphocytes. Cell 68:869.
32. Kao, C., Daniels, M. A. and Jameson, S. C. 2005. Loss of CD8 and TCR binding to Class I MHC ligands following T cell activation. Int. Immunol. 17:1607.
33. Drake, D. R. 3rd, Ream, R. M., Lawrence, C. W. and Braciale, T. J. 2005. Transient loss of MHC class I tetramer binding after CD8+ T cell activation reflects altered T cell effector function. J. Immunol. 175:1507.
34. Beyersdorf, N. B., Ding, X., Karp, K. and Hanke, T. 2001. Expression of inhibitory "killer cell lectin-like receptor G1" identifies unique subpopulations of effector and memory CD8 T cells. Eur. J. Immunol. 31:3443.
35. Robbins, S. H., Terrizzi, S. C., Sydora, B. C., Mikayama, T. and Brossay, L. 2003. Differential regulation of killer cell lectin-like receptor G1 expression on T cells. J. Immunol. 170:5876.
36. Joshi, N. S., Cui, W., Chandele, A. et al. 2007. Inflammation directs memory precursor and short-lived effector CD8(+) T cell fates via the graded expression of T-bet transcription factor. Immunity 27:281.
37. Kaech, S. M., Tan, J. T., Wherry, E. J., Konieczny, B. T., Surh, C. D. and Ahmed, R. 2003. Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat. Immunol. 4:1191.
38. Wilson, D. C., Matthews, S. and Yap, G. S. 2008. IL-12 signaling drives CD8+ T cell IFN-gamma production and differentiation of KLRG1+ effector subpopulations during Toxoplasma gondii infection. J. Immunol. 180:5935.
39. Pearce, E. L. and Shen, H. 2007. Generation of CD8 T cell memory is regulated by IL-12. J. Immunol. 179:2074.
40. Chen, C., Edelstein, L. C. and Gelinas, C. 2000. The Rel/NFkappaB family directly activates expression of the apoptosis inhibitor Bcl-x(L). Mol. Cell Biol. 20:2687.
41. Matter, M. S., Claus, C. and Ochsenbein, A. F. 2008. CD4+ T cell help improves CD8+ T cell memory by retained CD27 expression. Eur. J. Immunol. 38:1847.
42. Kaech, S. M., Wherry, E. J. and Ahmed, R. 2002. Effector and memory T-cell differentiation: implications for vaccine development. Nat. Rev. Immunol. 2:251.
43. Liou, H. C., Jin, Z., Tumang, J., Andjelic, S., Smith, K. A. and Liou, M. L. 1999. c-Rel is crucial for lymphocyte proliferation but dispensable for T cell effector function. Int. Immunol. 11:361.
44. Saibil, S. D., Jones, R. G., Deenick, E. K. et al. 2007. CD4+ and CD8+ T cell survival is regulated differentially by protein kinase Ctheta, c-Rel, and protein kinase B. J. Immunol. 178:2932.
45. Sanjabi, S., Hoffmann, A., Liou, H. C., Baltimore, D. and Smale, S. T. 2000. Selective requirement for c-Rel during IL-12 P40 gene induction in macrophages. Proc. Natl Acad. Sci. USA 97:12705.
46. Boffa, D. J., Feng, B., Sharma, V. et al. 2003. Selective loss of c-Rel compromises dendritic cell activation of T lymphocytes. Cell. Immunol. 222:105.
47. Wang, J., Wang, X., Hussain, S. et al. 2007. Distinct roles of different NF-kappa B subunits in regulating inflammatory and T cell stimulatory gene expression in dendritic cells. J. Immunol. 178:6777.
48. Tato, C. M., Mason, N., Artis, D. et al. 2006. Opposing roles of NF-kappaB family members in the regulation of NK cell proliferation and production of IFN-gamma. Int. Immunol. 18:505.
49. Isomura, I., Palmer, S., Grumont, R. J. et al. 2009. c-Rel is required for the development of thymic Foxp3+ CD4 regulatory T cells. J. Exp. Med. 206:3001.
50. Campbell, I. K., Gerondakis, S., O'Donnell, K. and Wicks, I. P. 2000. Distinct roles for the NF-kappaB1 (p50) and c-Rel transcription factors in inflammatory arthritis. J. Clin. Invest. 105:1799.
51. Kang, H., Remington, J. S. and Suzuki, Y. 2000. Decreased resistance of B cell-deficient mice to infection with Toxoplasma gondii despite unimpaired expression of IFN-gamma, TNF-alpha, and inducible nitric oxide synthase. J. Immunol. 164:2629.
52. Sayles, P. C., Gibson, G. W. and Johnson, L. L. 2000. B cells are essential for vaccination-induced resistance to virulent Toxoplasma gondii. Infect Immun. 68:1026.
53. Menard, L. C., Minns, L. A., Darche, S. et al. 2007. B cells amplify IFN-gamma production by T cells via a TNF-alpha-mediated mechanism. J. Immunol. 179:4857.
54. Whitmire, J. K., Asano, M. S., Kaech, S. M. et al. 2009. Requirement of B cells for generating CD4+ T cell memory. J. Immunol. 182:1868.
55. Harris, T. H., Wilson, E. H. and Tait, E. D. 2010. NF-kappaB1 contributes to T cell-mediated control of Toxoplasma gondii in the CNS. J. Neuroimmunol. 222:19.
56. Grumont, R., Hochrein, H., O'Keeffe, M. et al. 2001. c-Rel regulates interleukin 12 p70 expression in CD8(+) dendritic cells by specifically inducing p35 gene transcription. J. Exp. Med. 194:1021.
57. O'Keeffe, M., Grumont, R. J., Hochrein, H. et al. 2005. Distinct roles for the NF-kappaB1 and c-Rel transcription factors in the differentiation and survival of plasmacytoid and conventional dendritic cells activated by TLR-9 signals. Blood 106:3457.
58. Pepper, M., Dzierszinski, F., Wilson, E. et al. 2008. Plasmacytoid dendritic cells are activated by Toxoplasma gondii to present antigen and produce cytokines. J. Immunol. 180:6229.
59. Xiao, Z., Casey, K. A., Jameson, S. C., Curtsinger, J. M. and Mescher, M. F. 2009. Programming for CD8 T cell memory development requires IL-12 or type I IFN. J. Immunol. 182:2786.
60. Valenzuela, J., Schmidt, C. and Mescher, M. 2002. The roles of IL-12 in providing a third signal for clonal expansion of naive CD8 T cells. J. Immunol. 169:6842.
61. Curtsinger, J. M., Valenzuela, J. O., Agarwal, P., Lins, D. and Mescher, M. F. 2005. Type I IFNs provide a third signal to CD8 T cells to stimulate clonal expansion and differentiation. J. Immunol. 174:4465.
62. Takemoto, N., Intlekofer, A. M., Northrup, J. T., Wherry, E. J. and Reiner, S. L. 2006. Cutting Edge: IL-12 inversely regulates T-bet and eomesodermin expression during pathogen-induced CD8+ T cell differentiation. J. Immunol. 177:7515.
63. Keppler, S. J., Theil, K., Vucikuja, S. and Aichele, P. 2009. Effector T-cell differentiation during viral and bacterial infections: role of direct IL-12 signals for cell fate decision of CD8(+) T cells. Eur. J. Immunol. 39:1774.
64. Wherry, E. J. and Ahmed, R. 2004. Memory CD8 T-cell differentiation during viral infection. J. Virol. 78:5535.
65. Bustamante, J. M., Bixby, L. M. and Tarleton, R. L. 2008. Druginduced cure drives conversion to a stable and protective CD8+ T central memory response in chronic Chagas disease. Nat. Med. 14:542.
66. Bixby, L. M. and Tarleton, R. L. 2008. Stable CD8+ T cell memory during persistent Trypanosoma cruzi infection. J. Immunol. 181:2644.
67. Intlekofer, A. M., Takemoto, N., Wherry, E. J. et al. 2005. Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin. Nat. Immunol. 6:1236.
68. Tian, W. and Liou, H. C. 2009. RNAi-mediated c-Rel silencing leads to apoptosis of B cell tumor cells and suppresses antigenic immune response in vivo. PLoS One 4:e5028.